Synergistic enhancement of spinal fusion in preclinical models using low-dose rhBMP-2 and stromal vascular fraction in an injectable hydrogel composite

Spinal fusion surgery remains a significant challenge due to limitations in current bone graft materials, particularly in terms of bioactivity, integration, and safety. This study presents an innovative approach using an injectable hydroxyapatite/β-tricalcium phosphate (HA/β-TCP) hydrogel combined w...

Full description

Saved in:
Bibliographic Details
Main Authors: Hye Yeong Lee, Seong Bae An, Sae Yeon Hwang, Gwang Yong Hwang, Hye-Lan Lee, Hyun Jung Park, Joongkyum Shin, Keung Nyun Kim, Sung Won Wee, Sol Lip Yoon, Yoon Ha
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S259000642400440X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533330588172288
author Hye Yeong Lee
Seong Bae An
Sae Yeon Hwang
Gwang Yong Hwang
Hye-Lan Lee
Hyun Jung Park
Joongkyum Shin
Keung Nyun Kim
Sung Won Wee
Sol Lip Yoon
Yoon Ha
author_facet Hye Yeong Lee
Seong Bae An
Sae Yeon Hwang
Gwang Yong Hwang
Hye-Lan Lee
Hyun Jung Park
Joongkyum Shin
Keung Nyun Kim
Sung Won Wee
Sol Lip Yoon
Yoon Ha
author_sort Hye Yeong Lee
collection DOAJ
description Spinal fusion surgery remains a significant challenge due to limitations in current bone graft materials, particularly in terms of bioactivity, integration, and safety. This study presents an innovative approach using an injectable hydroxyapatite/β-tricalcium phosphate (HA/β-TCP) hydrogel combined with stromal vascular fraction (SVF) and low-dose recombinant human BMP-2 (rhBMP-2) to enhance osteodifferentiation and angiogenesis. Through a series of in vitro studies and preclinical models involving rats and minipigs, we demonstrated that the hydrogel system enables the sustained release of rhBMP-2, resulting in significantly improved bone density and integration, alongside reduced inflammatory responses. The combination of rhBMP-2 and SVF in this injectable formulation yielded superior spinal fusion outcomes, with enhanced mechanical properties and increased bone mass in both small and large animal models. These findings suggest that this strategy offers a promising and safer alternative for spinal fusion, with strong potential for clinical application.
format Article
id doaj-art-b7df3cc916fc42e2829351f1f2ea73a9
institution Kabale University
issn 2590-0064
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj-art-b7df3cc916fc42e2829351f1f2ea73a92025-01-17T04:52:01ZengElsevierMaterials Today Bio2590-00642025-02-0130101379Synergistic enhancement of spinal fusion in preclinical models using low-dose rhBMP-2 and stromal vascular fraction in an injectable hydrogel compositeHye Yeong Lee0Seong Bae An1Sae Yeon Hwang2Gwang Yong Hwang3Hye-Lan Lee4Hyun Jung Park5Joongkyum Shin6Keung Nyun Kim7Sung Won Wee8Sol Lip Yoon9Yoon Ha10Spine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of KoreaDepartment of Neurosurgery, School of Medicine, CHA University, CHA Bundang Medical Center, Seongnam-si, 13496, Gyeonggi-do, Republic of Korea; Graduate School, College of Medicine, Yonsei University, Seoul, 03722, Republic of KoreaSpine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of KoreaSpine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of KoreaSpine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of KoreaDepartment of Research Center, CGBio., co. Ltd, Seongnam-si, Gyeonggi-do, Republic of KoreaSpine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of KoreaSpine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of KoreaSpine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of KoreaSpine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of KoreaSpine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of Korea; POSTECH Biotech Center, Pohang University of Science and Technology (POSTECH), Pohang, Gyeongbuk, 37673, Republic of Korea; Corresponding author. Spine & Spinal Cord Institute, Department of Neurosurgery, College of Medicine, Yonsei University, Seoul, 03722, Republic of Korea.Spinal fusion surgery remains a significant challenge due to limitations in current bone graft materials, particularly in terms of bioactivity, integration, and safety. This study presents an innovative approach using an injectable hydroxyapatite/β-tricalcium phosphate (HA/β-TCP) hydrogel combined with stromal vascular fraction (SVF) and low-dose recombinant human BMP-2 (rhBMP-2) to enhance osteodifferentiation and angiogenesis. Through a series of in vitro studies and preclinical models involving rats and minipigs, we demonstrated that the hydrogel system enables the sustained release of rhBMP-2, resulting in significantly improved bone density and integration, alongside reduced inflammatory responses. The combination of rhBMP-2 and SVF in this injectable formulation yielded superior spinal fusion outcomes, with enhanced mechanical properties and increased bone mass in both small and large animal models. These findings suggest that this strategy offers a promising and safer alternative for spinal fusion, with strong potential for clinical application.http://www.sciencedirect.com/science/article/pii/S259000642400440XInjectable puttyStromal vascular fractionLow-dose recombinant human BMP-2Osteodifferentiation and angiogenesisSynergySpinal fusion surgery
spellingShingle Hye Yeong Lee
Seong Bae An
Sae Yeon Hwang
Gwang Yong Hwang
Hye-Lan Lee
Hyun Jung Park
Joongkyum Shin
Keung Nyun Kim
Sung Won Wee
Sol Lip Yoon
Yoon Ha
Synergistic enhancement of spinal fusion in preclinical models using low-dose rhBMP-2 and stromal vascular fraction in an injectable hydrogel composite
Materials Today Bio
Injectable putty
Stromal vascular fraction
Low-dose recombinant human BMP-2
Osteodifferentiation and angiogenesis
Synergy
Spinal fusion surgery
title Synergistic enhancement of spinal fusion in preclinical models using low-dose rhBMP-2 and stromal vascular fraction in an injectable hydrogel composite
title_full Synergistic enhancement of spinal fusion in preclinical models using low-dose rhBMP-2 and stromal vascular fraction in an injectable hydrogel composite
title_fullStr Synergistic enhancement of spinal fusion in preclinical models using low-dose rhBMP-2 and stromal vascular fraction in an injectable hydrogel composite
title_full_unstemmed Synergistic enhancement of spinal fusion in preclinical models using low-dose rhBMP-2 and stromal vascular fraction in an injectable hydrogel composite
title_short Synergistic enhancement of spinal fusion in preclinical models using low-dose rhBMP-2 and stromal vascular fraction in an injectable hydrogel composite
title_sort synergistic enhancement of spinal fusion in preclinical models using low dose rhbmp 2 and stromal vascular fraction in an injectable hydrogel composite
topic Injectable putty
Stromal vascular fraction
Low-dose recombinant human BMP-2
Osteodifferentiation and angiogenesis
Synergy
Spinal fusion surgery
url http://www.sciencedirect.com/science/article/pii/S259000642400440X
work_keys_str_mv AT hyeyeonglee synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT seongbaean synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT saeyeonhwang synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT gwangyonghwang synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT hyelanlee synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT hyunjungpark synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT joongkyumshin synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT keungnyunkim synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT sungwonwee synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT sollipyoon synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite
AT yoonha synergisticenhancementofspinalfusioninpreclinicalmodelsusinglowdoserhbmp2andstromalvascularfractioninaninjectablehydrogelcomposite